MD SB144 | 2022 | Regular Session

Status

Completed Legislative Action
Spectrum: Partisan Bill (Democrat 1-0)
Status: Passed on May 12 2022 - 100% progression
Action: 2022-05-12 - Approved by the Governor - Chapter 306
Text: Latest bill text (Chaptered) [PDF]

Summary

Repealing certain provisions of law relating to the prescription, administration, and regulation of amygdalin.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health - Authorization to Prescribe and Administer Amygdalin - Repeal

Sponsors


Roll Calls

2022-03-31 - House - Third Reading Passed (Y: 131 N: 0 NV: 2 Abs: 8) [PASS]
2022-02-24 - Senate - Third Reading Passed (Y: 45 N: 0 NV: 0 Abs: 2) [PASS]

History

DateChamberAction
2022-05-12SenateApproved by the Governor - Chapter 306
2022-03-31SenateReturned Passed
2022-03-31HouseThird Reading Passed (131-0)
2022-03-30HouseFavorable Adopted Second Reading Passed
2022-03-30HouseFavorable Report by Health and Government Operations
2022-03-18HouseHearing 3/23 at 1:30 p.m.
2022-03-01HouseReferred Health and Government Operations
2022-02-24SenateThird Reading Passed (45-0)
2022-02-22SenateSecond Reading Passed
2022-02-22SenateFavorable Adopted
2022-02-21SenateFavorable Report by Finance
2022-01-20SenateHearing 2/10 at 1:00 p.m.
2022-01-12SenateFirst Reading Finance
2021-09-22SenatePre-filed

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
Health - General18302(n/a)See Bill Text

Maryland State Sources


Bill Comments

feedback